Navigation Links
Controversial Vaccine Raises Fury of the Church

The controversial vaccine, Gardasil, against cervical cancer could be given to schoolgirls from the age of nine to protect them against the cervical cancer causing virus,// HPV, according to yesterday’s report.

However Scots church leaders have condemned the move saying that the vaccine is giving the "green light" to under-age sex. It is because of such concerns that other countries; most notably the US has resisted vaccinating young girls as yet.

Trials of Gardasil have been completed in Glasgow successfully and administration of the drug is planned across Scotland and the rest of the UK.

Although the Joint Committee on Vaccination and Immunization was presented with research that suggested that parents supported the introduction of the drug, Gardasil still needs the approval of the Department of Health and the Scottish Executive before vaccinations can be provided in schools. It is believed that pharmaceutical firms Merck and Co and Sanofi Pasteur have already met the executive with proposals for introduction of the drug.

A spokesman for the Catholic Church said: "Our concern would be that this vaccine is seen as giving the green light to promiscuity on the grounds that the vaccine protects young people from developing the virus that is the main cause of cervical cancer."

However the rates of cervical cancer in some part of Scotland are almost a third higher than the national average thereby Scots politicians have supported the newly proposed vaccination scheme.

Roseanna Cunningham, SNP chairwoman of the Scottish Parliament's health committee, said: "Any form of vaccination that can prevent disease should be seriously considered. I don't believe there is a morality issue because it is an intervention against a deadly disease."

In addition an executive spokesman said, "We are aware of the vaccine and the clinical trials which have taken place. No decision has yet been made about its use i n Scotland."

So far trials of Gardisal on 300 women aged between 16 and 23 in Glasgow, and other countries has suggested that it is most effective when it is administered to young women before they become sexually active
'"/>




Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Controversial deal on public access of the human genome map
3. Controversial Levis jean ad to be withdrawn
4. GMC Gives Controversial Fertility Doctor, A Clean Chit
5. Controversial Theory Says DNA Can Be Pushed To "Dark States"
6. Harvard Begins Controversial Human Stem Cell Cloning Project
7. The Controversial Stem Cell Transplant Surgery a Failure, Patient died
8. USDA Gives Go-Ahead to Market Controversial Genetically Engineered Rice, LL601
9. Ever-Controversial Mental Health Act To Be Decided Upon
10. Vaccine to quit smoking?
11. First Vaccine Designed for Africa Cleared for Testing in Humans
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2016)... , ... April 28, 2016 , ... ... is proud to partner with AquaShieldUSA, the country's oldest waterproof cast protector ... and medical supply stores, the largest selection of daily, night, weatherproof and waterproof ...
(Date:4/28/2016)... ... April 28, 2016 , ... The ... successful events, attracting medical professionals from around the globe who attended a week’s ... Opening Ceremonies Sunday, April 17 included the introduction of the 2016 ARRS Distinguished ...
(Date:4/28/2016)... ... April 28, 2016 , ... In many parts of the ... of childhood mortality. This is particularly true in underdeveloped parts of Africa where clean ... of New England’s campus in Tangier, Morocco, will examine this global health issue and ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... Year at VitaFoods 2016. , Nominated in the Healthy Ageing category, Cognizin® is ... and safety. The Healthy Ageing division can include everything from antioxidants, lipids, proteins, ...
(Date:4/28/2016)... , ... April 28, 2016 , ... ... in Aesthetic Surgery Education and Anzu®, developers of the AnzuMedical™ Knowledge Sharing ... Plastic Surgery Collaborative Residency Network. The platform is scheduled to launch in July ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... , April 27, 2016 ... announced the launch of a Phase 2 clinical study ... hearing in patients undergoing cochlear implantation (CI) surgery. This ... patients in Germany and ... the middle ear at the time of surgery. "Despite ...
(Date:4/26/2016)... 26, 2016 US demand for infection ... 4.9 percent annually to $27.6 billion in 2020.  ... to decrease rates of healthcare-associated infections (HAIs) will ... and services.  Although declining, the overall rate of ... levels set by the CDC.  Recent statistics indicate ...
(Date:4/26/2016)... Bayer AG has reported first-quarter ... and amortization. The earnings are the result of a ... Xarelto and Eylea, drugs Bayer is banking on to ... date was extended by four years this week to ... to reach a value of USD 1,147.1 billion ...
Breaking Medicine Technology: